Allogeneic and Autologous Bone Marrow Transplantation in Acute Leukemia: The Essen Experience
Chemo-/radiotherapy followed by bone marrow transplantation from sibling donors has been used successfully in many centers to treat patients with leukemia in whom primary chemotherapy failed or who were at high risk for relapses after therapy. However, only 30%–40% of patients have a matched allogeneic marrow donor. Therefore several groups initiated programs of autologous bone marrow transplantation with or without attempts to remove residual leukemic cells from the transplant by in vitro purging methods.
KeywordsLeukemia Corticosteroid Pneumonia Methotrexate Peri
Unable to display preview. Download preview PDF.
- 1.Schaefer UW (1985) Preservation of bone mar-row for transplantation. In: van Bekkum D, Löwenberg B (eds) Bone marrow transplantation. Dekker, New York, pp 513–538Google Scholar
- 2.Molls M, Bamberg M, Beelen DW, Mahmoud HK, Quast U, Schaefer UW (1987) Different TBI procedures in Essen: results and clinical considerations on the risk of leukemic relapse and interstitial pneumonitis. Strahlenther Onkol 163: 237–240Google Scholar
- 5.Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Doney K, Farewell V, Hansen J, Hill R, Lum L, Martin P, McGuffin R, Sanders J, Stewart P, Sullivan K, Witherspoon R, Yee G, Thomas ED (1986) Methotrexate and cyclosporine compared with cyclosporine alone for porphylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 314: 729–735PubMedCrossRefGoogle Scholar
- 6.Beelen DW, Graeven U, Schulz G, Grosse- Wilde H, Doxiadis I, Schaefer UW, Quabeck K, Sayer H, Schmidt CG (1988) Treatment of acute graft-versus-host disease after HLA-partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase-I/II trial. Onkologie 11: 56–58Google Scholar